Mirtazapine structure
|
Common Name | Mirtazapine | ||
---|---|---|---|---|
CAS Number | 85650-52-8 | Molecular Weight | 265.353 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 432.4±45.0 °C at 760 mmHg | |
Molecular Formula | C17H19N3 | Melting Point | 114-116ºC | |
MSDS | Chinese USA | Flash Point | 215.3±28.7 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of MirtazapineMirtazapine is a potent tetracyclic antidepressant.Target: 5-HT ReceptorMirtazapine, the novel antidepressant, has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors [1].Mirtazapine appears to have a substantial ameliorating effect on hot flushes and perspiration bouts. It is postulated that the 5-HT(2A) blocking properties of mirtazapine is accounted in the symptomatic relief of hot flushes [2]. After 4-24 weeks of treatment, mirtazapine induced downregulation of platelet alpha(2A)-adrenoceptors (up to 34%) and Galphai proteins (up to 28%), and the upregulation of GRK 2 (up to 30%). Treatment with mirtazapine reversed this abnormality and induced downregulation of alpha(2A)-adrenoceptor/Galphai complex [3]. |
Name | Mirtazapine |
---|---|
Synonym | More Synonyms |
Description | Mirtazapine is a potent tetracyclic antidepressant.Target: 5-HT ReceptorMirtazapine, the novel antidepressant, has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors [1].Mirtazapine appears to have a substantial ameliorating effect on hot flushes and perspiration bouts. It is postulated that the 5-HT(2A) blocking properties of mirtazapine is accounted in the symptomatic relief of hot flushes [2]. After 4-24 weeks of treatment, mirtazapine induced downregulation of platelet alpha(2A)-adrenoceptors (up to 34%) and Galphai proteins (up to 28%), and the upregulation of GRK 2 (up to 30%). Treatment with mirtazapine reversed this abnormality and induced downregulation of alpha(2A)-adrenoceptor/Galphai complex [3]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 432.4±45.0 °C at 760 mmHg |
Melting Point | 114-116ºC |
Molecular Formula | C17H19N3 |
Molecular Weight | 265.353 |
Flash Point | 215.3±28.7 °C |
Exact Mass | 265.157898 |
PSA | 19.37000 |
LogP | 2.75 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.668 |
Storage condition | Store at RT |
Water Solubility | DMSO: ~8 mg/mL, soluble |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H336 |
Precautionary Statements | P301 + P312 + P330 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
Hazard Codes | Xn |
Risk Phrases | 22 |
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2933990090 |
~94% Mirtazapine CAS#:85650-52-8 |
Literature: Singer, Claude; Liberman, Anita; Finkelstein, Nina Patent: US2001/51718 A1, 2001 ; Title/Abstract Full Text Show Details Singer, Claude; Liberman, Anita; Finkelstein, Nina Patent: US2003/69417 A1, 2003 ; |
~82% Mirtazapine CAS#:85650-52-8 |
Literature: N.V. ORGANON Patent: WO2008/125578 A2, 2008 ; Location in patent: Page/Page column 16 ; |
~55% Mirtazapine CAS#:85650-52-8 |
Literature: N.V. Organon Patent: US2008/255349 A1, 2008 ; Location in patent: Page/Page column 9 ; |
~% Mirtazapine CAS#:85650-52-8 |
Literature: WO2008/125577 A1, ; Page/Page column 22 ; |
~% Mirtazapine CAS#:85650-52-8 |
Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
~% Mirtazapine CAS#:85650-52-8 |
Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
~% Mirtazapine CAS#:85650-52-8 |
Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
~% Mirtazapine CAS#:85650-52-8 |
Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402 |
Precursor 7 | |
---|---|
DownStream 3 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Biochem. Pharmacol. 95 , 311-23, (2015) Different lines of evidence indicate that the lysophosphatidic acid (LPA) receptor LPA1 is involved in neurogenesis, synaptic plasticity and anxiety-related behavior, but little is known on whether th... |
|
Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014) • The introduction has been modified. • More references have been added to the text. • Limitations of the method have been discussed more in detail. |
|
Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 993-994 , 26-35, (2015) This study reports on the development of a rapid, selective, and sensitive column-switching liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to analyze sixteen drugs (antidepressants, ... |
Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl- |
Zispin |
(14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO[2.1-A]PYRIDO[2.3-C][2]BENZAZEPINE |
Mirtazapin |
1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO[2,1-A]PYRIDO[2,3-C][2]BENZAZEPINE |
Remeron |
ORG-3770 |
UNII:A051Q2099Q |
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
MIRTAZEPINE |
2-Methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine |
Mirtazanine |
Avanza |
MFCD00865427 |
MIRTAZAPINE ANHYDRUOS |
EINECS 288-060-6 |